Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.49%), DAX (0.82%), CAC40 (0.39%)

Jul 17 ,2026

  • Synopsis

    • European equity markets set to open lower, having closed mixed yesterday. Asian equities sharply lower Friday with semis/memory and SoftBank driving selloff in Japan and Taiwan. S&P 500 futures weakening after hours following mostly lower close overnight. Bonds mixed with JGB curve steepening while Treasury yields down 1-2 bp. Crude extending rebound from lows. Gold unchanged while silver extending declines. Dollar steady against majors, yen continues to consolidate while Korean won holding at two-month high. Bitcoin retreating further.

    • On the agenda for today, focus will turn to the UK as Andy Burnham is set to become Labour leader today at a formal ceremony in London. Burnham will not officially become the PM until 20-Jul following the required constitutional sequence of events. Elsewhere, Chancellor Merz and French President Macron jointly chair Franco-German Council of Ministers as well as Defense and Security Council. Focus in Europe still on Q2 results amidst a busy morning for earnings out of Sweden.

    • In macro releases, Austria Jun final CPI out at 8:00 BST, followed by Italy May Construction Output at 9:00 BST and Eurozone Jun final CPI due at 10:00 BST.

  • Politics/Macro/World News:

    • Central Bank:

      • ECB set to wait for September to hike one last time, poll shows (Bloomberg )

      • Investors say BoE should slow or stop long-dated bond sales (FT )

    • UK:

      • Andy Burnham will promise a new path for Britain in a speech as he becomes the new Labour leader on Friday (BBC )

      • UK mortgage rates rise again after resumption of Middle East hostilities (FT )

    • Politics:

      • As Le Pen looms, Macron and Merz bid to show Franco-German engine still has clout (Politico )

  • Top company news

    • Earnings/updates

      • DKSH.SW (DKSH Holding) -- H1 EPS CHF1.67 vs consensus CHF1.60; management remains confident in delivering sustainable Core EBIT growth, reaffirms mid-term roadmap

      • TOM.NO (Tomra Systems) -- Q2 adj. EPS €0.10 vs FactSet €0.09 [9 est, €0.07-0.10]

      • DBV.FP (DBV Technologies) -- Q2 EPS ($0.12) vs FactSet ($0.11) [5 est, ($0.12)-(0.10)]

      • SKA.B.SS (Skanska) -- Q2 EPS SEK4.27 vs FactSet SEK4.29 [5 est, SEK4.07-4.71] (SEK 252.30)

      • VOLV.B.SS (Volvo) -- Q2 EPS SEK5.10 vs consensus SEK5.22; comments on US tariffs impact on operating income

      • DG.FP (VINCI SA) -- Jun airport passenger traffic (2.6%)

      • SKF.B.SS (SKF) -- Q2 adj EPS SEK4.98 vs FactSet SEK3.68 [14 est, SEK2.56-4.89]; expects organic sales to strengthen somewhat in Q3

      • SAAB.B.SS (Saab) -- Q2 EPS SEK3.96 vs FactSet SEK3.43 [7 est, SEK3.09-3.72]

      • DANSKE.DC (Danske Bank) -- Q2 net income DKK6.20B vs consensus DKK5.92B (DKK 370.00); raises FY net income guidance

      • ADP.FP (Aeroport de Paris) -- Total Paris Aeroport Jun traffic 9.38M, (3.2%) y/y

      • HUSQ.B.SS (Husqvarna) -- Q2 EPS (ex IAC) SEK2.27 vs consensus SEK2.05

      • TELIA.SS (Telia Co.) -- Q2 EPS SEK0.57 vs consensus SEK0.55; reiterates 2026 outlook

      • SWED.A.SS (Swedbank) -- Q2 EPS SEK6.37 vs consensus SEK6.36

      • S92.GR (SMA Solar Technology) -- prelim Q2 results; raises FY 2026 guidance

      • EQT.SS (EQT AB) -- H1 total AUM €291B vs year-ago €266B

      • VOLCAR.B.SS (Volvo Car) -- Q2 EPS SEK0.42 vs FactSet SEK0.31 [6 est, SEK0.19-0.45]

      • LIAB.SS (Lindab International) -- Q2 EPS SEK1.77 vs FactSet SEK2.08 [5 est, SEK1.88-2.30]

      • BILL.SS (Billerud) -- Q2 EPS (SEK0.26) vs FactSet (SEK0.69) [9 est, (SEK0.91)-(0.33)]

      • SAVE.SS (Nordnet) -- Q2 EPS SEK3.80 vs FactSet SEK3.47 [11 est, SEK3.36-3.60]

      • GF.SW (Georg Fischer) -- H1 net income (CHF77M) vs FactSet (CHF84.5M) [2 est, (CHF99)-(70M)]

      • BHG.SS (Lightshop) -- Q2 EPS SEK0.31 vs FactSet SEK0.42 [4 est, SEK0.39-0.46]

      • CEVI.SS (CellaVision) -- Q2 EPS SEK1.37 vs FactSet SEK1.34 [2 est, SEK1.21-1.47]

      • FQT.GR (Frequentis) -- prelim H1 EBIT €15M vs year ago (€4.3M)

    • M&A

      • EXM.BB (Exmar NV) -- to sell midsize gas carriers KORTRIJK, WEPION and KRUIBEKE; to sell fully pressurized vessels JOAN and ELISABETH

      • DSY.FP (Dassault Systemes) -- in discussions to acquire drug trial software maker ArisGlobal for ~$2B - Financial Times

      • BMPS.IM (Banca Monte dei Paschi di Siena) -- board reports preliminary observations on the public tender and exchange offer launched by Intesa Sanpaolo

      • ZAB.PW (Zabka Group) -- Seven & I Holdings confirms discussions regarding potential investment in Zabka; no decisions have been made

      • AED.BB (Aedifica) -- acquires two care properties in Spain and Finland for €21M

      • TRUE.B.SS (Truecaller) -- to acquire TextPlus for $15M in cash

      • LBIRD.FP (Lumibird) -- enters negotiations for sale of its Medical Division to IPG Photonics, for enterprise value €300M, plus potential earn-out up to €50M

      • GCARSOA1.MM (Grupo Carso SAB de CV) -- Grupo Carso SAB de CV reports on binding agreement with Total Energies EP regarding Mexico Block 30

    • Healthcare

      • NOVN.SW (Novartis) -- FDA grants Novartis traditional approval for Fabhalta (iptacopan) to slow kidney function decline in adults with primary immunoglobulin A nephropathy at risk of disease progression

      • DBV.FP (DBV Technologies) -- SEC filing: 10-Q

      • CAMX.SS (Camurus) -- announces FDA has accepted for review resubmission of NDA for CAM2029 for treatment of patients with acromegaly

      • COTN.SW (COMET Holding) -- Ninth Circuit Court of Appeals in San Francisco rules a new trial is necessary following appeal by XP Power in Comet Technologies case

    • Other

      • AMUN.FP (Amundi) -- announces that IPO offering of SBI Funds Management Ltd is expected to generate a capital gain of ~€300M

      • BA.LN (BAE Systems) -- named principal contractor for $1.96B sale to Kingdom of Saudi Arabia (15-Jul, timing uncertain)

      • AC.FP (Accor) -- investigated CEO Sébastien Bazin's conduct, found no wrongdoing - FT

      • TRUE.B.SS (Truecaller) -- enters into SEK 850M term loan facility

      • CINT.SS (Cint Group) -- applies to delist shares from Nasdaq Stockholm

  • Key rating changes

    • Upgrades

      • INRN.SW (Interroll Holding) -- to hold from reduce at Kepler Cheuvreux

      • TEL.NO (Telenor) -- to buy from hold at Pareto

      • SGRO.LN (Segro) -- to buy from hold at Kepler Cheuvreux

      • ADEN.SW (Adecco Group) -- to outperform from neutral at BNP Paribas Exane

      • IHP.LN (Integrafin Holdings) -- to buy from hold at Jefferies

      • NWG.LN (NatWest Group) -- to outperform from market perform at Keefe, Bruyette & Woods

      • ABB.SS (ABB Limited) -- to buy at DNB Carnegie; to buy from hold at Pareto

      • NMAN.SS (Nederman Holding) -- to buy from hold at DNB Carnegie

      • BMW.GR (Bayerische Motoren Werke) -- to buy from hold at HSBC

      • TREL.B.SS (Trelleborg) -- to hold from sell at ABG Sundal Collier

    • Downgrades

      • AF.FP (Air France-KLM) -- to reduce from hold at Kepler Cheuvreux

      • DHER.GR (Delivery Hero) -- to neutral from buy at UBS

      • LLOY.LN (Lloyds Banking Group) -- to market perform from outperform at Keefe, Bruyette & Woods

      • SOBI.SS (Swedish Orphan Biovitrum) -- to hold from buy at DNB Carnegie

      • OUT1V.FH (Outokumpu) -- to hold from buy at SEB

      • DEMANT.DC (Demant) -- to market perform from outperform at Bernstein

  • Data

    • Nikkei (5.37%) to 63245.23

    • Hang Seng (2.55%) to 24371.98

    • Shanghai Composite (3.05%) to 3764.05

    • S&P futures (71.3) vs prior close of 7577.8

    • €-$ (0.0001) or (0.01%) to 1.1442

    • $-¥ +0.02 or +0.02% to 162.41

    • €-¥ (0.01) or (0.01%) to 185.80

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.